Biologic Treatment Options for Pityriasis Rubra Pilaris: An Evidence-Based Systematic Review

Description

Pityriasis rubra pilaris (PRP) is a rare inflammatory condition characterized by follicular hyperkeratosis and palmoplantar keratoderma. There are currently no FDA-approved therapies for PRP, however, use of biologics has been reported in literature. This systematic review summarizes evidence surrounding biologic treatment for PRP.

Categories

Licence